Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | mRNA-2736 |
Synonyms | |
Therapy Description |
Limited information is currently available on mRNA-2736 (Jul 2023). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
mRNA-2736 | mRNA2736|mRNA 2736 | Limited information is currently available on mRNA-2736 (Jul 2023). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|---|---|---|---|---|---|
NCT05918250 | Phase I | mRNA-2736 | mRNA-2736 for Participants With Relapsed or Refractory Multiple Myeloma (RRMM) | Withdrawn | USA | CAN | 0 |